Thank you, that makes sense after P3 trial.....I a
Post# of 148296
(Total Views: 167)
Posted On: 03/09/2019 1:04:20 AM
Thank you, that makes sense after P3 trial.....I also view this as more likely if priced competitively with other approved drugs. How common is it for insurance to accept “off-label” scripts? Believe me, I am optimistic about our future, but I want to have realistic expectations.
I guess at the moment, revenues don’t matter that much, but if combo approval is delayed 3 months, would reduce 2020 revenues from $580M to $435M. I think mono or cancer could make up for some of this, but personally I want to plan for the worst and be positively surprised for anything better!
I guess at the moment, revenues don’t matter that much, but if combo approval is delayed 3 months, would reduce 2020 revenues from $580M to $435M. I think mono or cancer could make up for some of this, but personally I want to plan for the worst and be positively surprised for anything better!
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
Scroll down for more posts ▼